Do not use solution that has been reconstituted for more than 28 days, even if it appears clear
Postprandial GLP-1, Norepinephrine, and Reactive Hypoglycemia in Dumping Syndrome
Several recent CVOTs have shown that GLP-1RAs can reduce the decline of estimated GFR (eGFR) and delay the onset of the occurrence of proteinuria in patients with T2DM [4, 22, 26, 46, 47]
The MHRA's position is clear: any medicine sold in the UK must hold a valid marketing authorisation , unless it is being administered within the context of a properly approved clinical trial or prescribed as a 'specials' medicine under tightly controlled circumstances
Key takeaways GLP-1 receptor agonists can help support healthy blood glucose levels and manage appetite with a range of approved indications
While it is still being studied in Phase 3 clinical trials, it has already been used for several years in research settings